These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2454367

  • 1. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Bartsch W, Sponer G, Strein K, Böhm E, Hooper RG.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mode of vasodilating action of carvedilol.
    Sponer G, Strein K, Müller-Beckmann B, Bartsch W.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists.
    Park KH, Long JP, Cannon JG.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H, Tanaka M, Kanda A, Akashi A.
    Drugs; 1988 Dec; 36 Suppl 6():31-6. PubMed ID: 2908302
    [Abstract] [Full Text] [Related]

  • 5. Postural hypotension in elderly patients given carvedilol.
    Krum H, Conway EL, Broadbear JH, Howes LG, Louis WJ.
    BMJ; 1994 Sep 24; 309(6957):775-6. PubMed ID: 7950564
    [No Abstract] [Full Text] [Related]

  • 6. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H, Kanda A, Hubo H, Tanaka M.
    J Cardiovasc Pharmacol; 1991 Sep 24; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [Abstract] [Full Text] [Related]

  • 7. A method for evaluating postural hypotension in conscious rabbits as a model to predict effects of drugs in man.
    Sponer G, Mannesmann G, Bartsch W, Dietmann K.
    J Pharmacol Methods; 1981 Jan 24; 5(1):53-8. PubMed ID: 7265985
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan 24; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH.
    Clin Investig; 1992 Jan 24; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.
    Strein K, Sponer G, Müller-Beckmann B, Bartsch W.
    J Cardiovasc Pharmacol; 1987 Jan 24; 10 Suppl 11():S33-41. PubMed ID: 2454365
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
    Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR.
    J Cardiovasc Pharmacol; 1987 Jan 24; 10 Suppl 11():S81-4. PubMed ID: 2454374
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive compounds with combined actions.
    Rahn KH.
    J Cardiovasc Pharmacol; 1987 Jan 24; 10 Suppl 11():S18-22. PubMed ID: 2454363
    [Abstract] [Full Text] [Related]

  • 15. A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension.
    Takata Y, Kurihara J, Suzuki S, Okubo Y, Kato H.
    Biol Pharm Bull; 1999 May 24; 22(5):457-62. PubMed ID: 10375164
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B, Cronin CJ, Graham BR, Prichard BN.
    J Cardiovasc Pharmacol; 1987 May 24; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A model of orthostatic hypotension in the conscious monkey using lower body negative pressure.
    Murphy DJ, Renninger JP, Ju H.
    J Pharmacol Toxicol Methods; 2006 May 24; 54(2):106-15. PubMed ID: 16650782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.